Dr. WANG Ming, MD, is currently the deputy chief physician of gastrointestinal surgery at Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine. In 2007, he graduated from Shanghai Jiaotong University School of Medicine (formerly Shanghai Second Medical University). After graduation, he has been working in General Surgery/Gastrointestinal Surgery of Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine. He is mainly engaged in clinical diagnosis and treatment of gastrointestinal tumors and related research work. From 2009 to 2012, he was under the tutelage of Professor Cao Hui, and received the joint training of Shanghai Jiaotong University School of Medicine and Shanghai Cancer Institute to obtain a doctorate degree. From 2013 to 2014, supported by the hospital, he went to the Department of Oncology, Heidelberg University Mannheim Hospital, Germany visiting study with Professor Peter Hohenberger, a famous European oncology expert. In 2017, he was appointed as the deputy chief physician of the Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine.

He is currently a member of the Chinese Society of Clinical Oncology (CSCO) Gastrointestinal Stromal Tumor Specialized Committee, a member and secretary of the Gastrointestinal Stromal Tumor Diagnosis and Treatment Committee of the Chinese Medical Doctor Association Surgeons Branch, and a Gastrointestinal Stromal Tumor Specialist Committee of the Chinese Medical Doctor Association Surgeons Branch. Deputy director of the Youth Committee of the Diagnosis and Treatment Professional Committee, etc.

 
Dr. Wang Ming is specialized in the surgical operation and comprehensive treatment of gastric cancer, colorectal cancer, gastrointestinal stromal tumor and other digestive tract tumors. He can independently perform laparoscopic total gastrectomy, laparoscopic pylorus-preserving gastrectomy (PPG), abdominal cavity Endoscopic total mesocolectomy (CME) colon cancer radical resection, laparoscopic total mesorectal excision (TME) rectal cancer radical resection, open pancreatoduodenectomy (PD) and other difficult operations in gastrointestinal surgery. In particular, he has extensive experience in minimally invasive surgery for gastrointestinal stromal tumors, surgical treatment of metastatic and recurrent gastrointestinal stromal tumors, and comprehensive treatment of gastrointestinal stromal tumors combined with targeted drugs and surgery.